Articles tagged with "Pharma"
Sort by
Bath combines biology and chemistry to thwart cancer drivers
March 4, 2026
University of Bath researchers are harnessing bacteria to develop millions of potential drug molecules inside living cells, in order to speed therapy development to combat hard-to-treat cancers.
How to solve a problem like implementing Electronic Lab Notebooks
February 22, 2026
Changing circumstances now favour more widespread adoption of Electronic Lab Notebooks. Yet the process requires careful planning, warns Samantha Pearman-Kanza, who shares her experience of the University of Southampton’s implementation...
Biosimilars and the post-patent environment
February 16, 2026
The market and frameworks for biologics and their biosimilars are growing and ever-evolving, as illustrated by the news around rheumatoid arthritis therapies. Isabel Murphy looks at their development, regulation and...
Scientists find sweet spot for tackling resistant pathogen
February 4, 2026
Australian researchers have designed antibodies able to recognise a sugar present only on bacterial cells.
Microscopes to market: Exporting for innovation
February 2, 2026
Lab and life science innovators often lack the knowledge and resources to expand into foreign markets. That’s where UK Export Finance could make a difference, says Tim Reid.
Study links variants in single gene to incidences of dementia
January 11, 2026
New research from UCL has identified variations in a single gene as an under-recognised target for dementia therapies.
ABPI and NCUB: lack of competitiveness undermining UK life sciences
September 13, 2025
Britain’s place as a global leader in the pharmaceutical and life sciences sectors has plunged in recent years, suggests a new industry report.
Fermenting resistance
March 24, 2025
A study revealed that cancer cells that developed a high fermentative capacity became resistant and ceased responding to drug treatment, outlines Antonio Mazzocca.
Wolfson grant enables purchase of world’s fastest scanning microscope
February 9, 2025
Pioneering dementia research professor Roslyn Bill has welcomed the announcement of a £0.5 million grant for Aston Institute for Membrane Excellence (AIME), saying it will help accelerate her collaborative work...
AstraZeneca’s Speke U-turn deals blow to Government’s life sciences ambition
February 3, 2025
AstraZeneca’s shock reversal of its plans to expand vaccine manufacturing at its Speke plant on Merseyside has put an end to hopes of the proposed £450 million investment in the...
Latest Digital Issue
